Mkts

Celularity Inc.

NASDAQ: CELU
$0.47-0.02 (-3.15%)
As of Nov 19, 4:00 PM ET

Key statistics

Day range
0.460.52
52-week range
0.472.55
Today
Open0.48
Previous close0.47
Volume—
Valuation
Market cap15.80M
P/E ratio—
EPS (TTM)-1.68
Income & risk
Dividend / yield—
Beta1.13
Avg volume2.82M
Discussion

CELU News

Stories mentioning CELU from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30Q1 '24Mar 31
Income Statement
Revenue4,1045,2845,73611,42618,1329,29612,11114,681
Cost of Goods Sold7,3743,9045,2423,5547,3433,8832,1231,640
Gross Profit(3,270)1,380494.007,87210,7895,4139,98813,041
Operating Expenses
Research & Development3,3474,5983,3523,7283,8283,9153,8005,843
Sales General & Admin15,0649,30612,63414,26216,05812,65015,90714,028
Total Operating Expenses
Operating Income (Loss)(22,058)(12,900)(15,864)(10,486)(9,280)(11,527)(10,175)(7,376)
Interest Income
Interest Expense
Other Expense
Pretax Income(24,359)(23,076)(24,524)(19,754)(13,293)(16,098)(6,488)(22,013)
Tax Provision0.000.000.00
Net Income (Loss)(24,362)(23,076)(24,524)(19,754)(13,293)(16,098)(6,488)(22,013)
Earnings Per Share (Basic)(0.95)(0.88)(1.02)(0.84)(0.61)(0.73)(0.30)(1.03)
Earnings Per Share (Diluted)(0.95)(0.88)(1.02)(0.84)(0.61)(0.73)(0.30)(1.03)
Weighted Average Shares Outstanding (Basic)25,59926,34824,02023,53121,89121,97621,85021,441
Weighted Average Shares Outstanding (Diluted)25,59926,34824,02023,53121,89121,97621,85021,441

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CELU

Celularity Inc. (NASDAQ: CELU) is a stock listed on the Nasdaq Stock Market under the ticker symbol CELU. It last traded at $0.4700 (Nov 19, 2026, 4:00 PM ET), down 3.1% on the day. That gives Celularity a market capitalisation of $15.8M.

Over the past 52 weeks CELU has traded between $0.4700 and $2.55.

Revenue for the quarter ended Dec 31, 2025 was $4.1M; a net loss of $24.4M. Revenue was down 77.4% from $18.1M in the quarter ended Dec 31, 2024.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Dec 31, 2025$4.1M-$24.4M-593.6%
Sep 30, 2025$5.3M-$23.1M-436.7%
Jun 30, 2025$5.7M-$24.5M-427.5%
Mar 31, 2025$11.4M-$19.8M-172.9%

From Celularity’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…